Compare

Akzo Nobel/€AKZA

1D1W1M3M6MYTD1Y5YMAX

About Akzo Nobel

Akzo Nobel is a global company headquartered in Amsterdam, Netherlands, specializing in the production of paints and coatings. Its core business operations include decorative paints and performance coatings, serving industries such as automotive, construction, and consumer goods. The company has a significant international presence, operating in numerous countries around the world. Akzo Nobel is known for its strong commitment to innovation and sustainability, aiming to create high-performance products with a reduced environmental impact. With a history dating back to 1792, Akzo Nobel has built a reputation for quality and reliability in its product offerings.
Ticker
€AKZA
Sector
Materials
Primary listing
AEX
Employees
29,900

Akzo Nobel Metrics

BasicAdvanced
€11B
16.88
€3.74
1.16
€1.98
3.14%

What the Analysts think about Akzo Nobel

Analyst ratings (Buy, Hold, Sell) for Akzo Nobel stock.
Analyst projections of the future price of Akzo Nobel stock.

Bulls say / Bears say

Pricing and cost savings are steadily improving profitability: the adjusted EBITDA margin rose to 15.3% in Q3, marking a sixth consecutive quarter of expansion. Adjusted EBITDA also grew 4% organically. (AkzoNobel)
The planned $1.35 billion sale of decorative paints in South East Asia values the business at 21 times FY25 EBITDA, which AkzoNobel says is more than twice its current trading multiple. The proceeds offer a chance to unlock value and support its balance sheet. (AkzoNobel)
The proposed Axalta merger could give the group broader global reach and a target of $600 million in annual cost synergies. The companies say it remains on track to close in early 2027, subject to regulatory approvals. (PCI Magazine, AkzoNobel)
Underlying demand remains soft: Q3 revenue was nearly flat, with organic growth driven by pricing rather than stronger volumes. AkzoNobel expects flat volumes in Q4, leaving little sign of a near-term demand recovery. (Chemweek, AkzoNobel)
Cash generation weakened: net cash from operating activities fell to €187 million in Q3 from €331 million a year earlier. Citi also said free cash flow was 49% below its consensus estimate, partly due to Axalta merger costs. (AkzoNobel, IEX)
The Axalta deal still needs regulatory clearance and requires AkzoNobel to sell its European vehicle-refinishing business. That would remove an established business from the portfolio, while the merger benefits remain dependent on a transaction expected to close in early 2027. (Chemweek)
Data summarised monthly by Lightyear AI. Last updated on 21 Oct 2026.

Akzo Nobel Financial Performance

Revenues and expenses
Income statement
AnnuallyQuarterly
2023
YoY growth
Revenue
Net income
Profit margin

Akzo Nobel Earnings Performance

Company profitability
Earnings per share
AnnuallyQuarterly
2020
2021
2022
2023
2024
Actual
Expected
Surprise

Funds containing Akzo Nobel

AllEURUSD
Funds
Fund name
Fund size
€AKZA weighting
iShares STOXX Europe 600 Chemicals€EXV7
€104M4.56%
iShares EURO STOXX Mid Cap£DJMC
€536M1.30%
iShares EURO STOXX Mid€DJMC
€536M1.29%
iShares AEX£IAEX
€761M0.96%
iShares AEX€IAEX
€761M0.96%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.